Towards a Unified Testing Framework for Single-Sided Deafness Studies: A Consensus Paper
| Autor: | Tobias Weissgerber, Mohan Kameswaran, Paul Van de Heyning, Susan Arndt, Erwin L. J. George, Daniel Polterauer, Rudolf Hagen, John Martin Hempel, Joachim Müller, Dayse Távora-Vieira, Hideaki Moteki, Astrid Wolf-Magele, Griet Mertens, Vincent Van Rompaey, Anja Kurz, Ryosuke Kitoh, Maiko Miyagawa, Ranjith Rajeswaran, Ruben Polo, Shin ichi Usami, Mario E. Zernotti, Gunesh P. Rajan, Kari Smilsky, Maria Fernanda Di Gregorio, Georg Mathias Sprinzl, Thomas Wesarg, Wolf Dieter Baumgartner, Robert J. Stokroos, Stefan Zirn, Ohad Hilly, Daniel Leander, María del Mar Medina, Uwe Baumann, Tobias Rader, David Ulanovski, Yael Henkin, Thomas Keintzel, Kristen Rak, Mathieu Marx |
|---|---|
| Přispěvatelé: | Centre de recherche cerveau et cognition (CERCO), Institut des sciences du cerveau de Toulouse. (ISCT), Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Otolaryngology and Head and Neck Surgery Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, KNO, MUMC+: MA AIOS Keel Neus Oorheelkunde (9), MUMC+: MA Keel Neus Oorheelkunde (9), MUMC+: MA Audiologisch Centrum Maastricht (9) |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Consensus Physiology Computer science Speech recognition medicine.medical_treatment Treatment outcome Audiology Deafness Hearing Loss Unilateral 03 medical and health sciences Speech and Hearing Tinnitus 0302 clinical medicine Bone conduction Hearing Aids Cochlear implant Surveys and Questionnaires medicine Journal Article Humans Comparative Study Longitudinal Studies Prospective Studies Sound Localization 030223 otorhinolaryngology Cochlear implantation Hearing Loss ComputingMilieux_MISCELLANEOUS Original Paper [SCCO.NEUR]Cognitive science/Neuroscience Bone-anchored hearing aid Unilateral medicine.disease Cochlear Implantation Sensory Systems Cochlear Implants Treatment Outcome Otorhinolaryngology Randomized Controlled Trial Quality of Life Speech Perception Human medicine medicine.symptom Routing (electronic design automation) Unilateral hearing loss Noise 030217 neurology & neurosurgery |
| Zdroj: | Audiology and Neurotology Audiology and Neurotology, 2016, 21 (6), pp.391--398. ⟨10.1159/000455058⟩ Audiology and neuro-otology Audiology and Neurotology, 21(6), 391-398. S. Karger AG |
| ISSN: | 1420-3030 |
| DOI: | 10.1159/000455058⟩ |
| Popis: | Background: While hearing aids for a contralateral routing of signals (CROS-HA) and bone conduction devices have been the traditional treatment for single-sided deafness (SSD) and asymmetric hearing loss (AHL), in recent years, cochlear implants (CIs) have increasingly become a viable treatment choice, particularly in countries where regulatory approval and reimbursement schemes are in place. Part of the reason for this shift is that the CI is the only device capable of restoring bilateral input to the auditory system and hence of possibly reinstating binaural hearing. Although several studies have independently shown that the CI is a safe and effective treatment for SSD and AHL, clinical outcome measures in those studies and across CI centers vary greatly. Only with a consistent use of defined and agreed-upon outcome measures across centers can high-level evidence be generated to assess the safety and efficacy of CIs and alternative treatments in recipients with SSD and AHL. Methods: This paper presents a comparative study design and minimum outcome measures for the assessment of current treatment options in patients with SSD/AHL. The protocol was developed, discussed, and eventually agreed upon by expert panels that convened at the 2015 APSCI conference in Beijing, China, and at the CI 2016 conference in Toronto, Canada. Results: A longitudinal study design comparing CROS-HA, BCD, and CI treatments is proposed. The recommended outcome measures include (1) speech in noise testing, using the same set of 3 spatial configurations to compare binaural benefits such as summation, squelch, and head shadow across devices; (2) localization testing, using stimuli that rove in both level and spectral content; (3) questionnaires to collect quality of life measures and the frequency of device use; and (4) questionnaires for assessing the impact of tinnitus before and after treatment, if applicable. Conclusion: A protocol for the assessment of treatment options and outcomes in recipients with SSD and AHL is presented. The proposed set of minimum outcome measures aims at harmonizing assessment methods across centers and thus at generating a growing body of high-level evidence for those treatment options. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|